Uganda [clinicaltrials_resource:53b3c88ea00c4f0e137b4e6fe7bd23f1]
Safety and Effectiveness of the Vaccine ALVAC-HIV vCP205 in HIV-Negative Adult Volunteers in Uganda [clinicaltrials:NCT00007423]Tuberculosis in HIV Infected Patients in Uganda [clinicaltrials:NCT00057421]Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis [clinicaltrials:NCT00078247]Safety of and Immune Response to an HIV-1 Vaccine (ALVAC-HIV vCP1521) in Infants Born to HIV Infected Mothers [clinicaltrials:NCT00098163]Mannitol as Adjunct Therapy for Childhood Cerebral Malaria [clinicaltrials:NCT00113854]Evaluation of Home-Based Management of Fever in Urban Ugandan Children [clinicaltrials:NCT00115921]A New Approach to Deliver Malaria Preventions to Pregnant Women at a Community Level in Uganda [clinicaltrials:NCT00118027]Home-based AIDS Care Project [clinicaltrials:NCT00119093]Longitudinal Antimalarial Combinations in Uganda [clinicaltrials:NCT00123552]Efficacy of Intrarectal Versus Intravenous Quinine for the Treatment of Childhood Cerebral Malaria [clinicaltrials:NCT00124267]Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the Community [clinicaltrials:NCT00124878]Influence of Chloroquine on HIV Viral Load Among Pregnant Women in Uganda [clinicaltrials:NCT00132535]Preventing Malaria During Pregnancy in Epidemic-Prone Areas. [clinicaltrials:NCT00142207]Comparison of Facility and Home-based ART Delivery Systems in Uganda [clinicaltrials:NCT00144365]The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda [clinicaltrials:NCT00215267]Epidemiology and Control of Mansonella Perstans Infection in Uganda [clinicaltrials:NCT00215280]Acceptability and Cost Effectiveness of Home Based Management of Fever: Different Strategies [clinicaltrials:NCT00259142]Rapid Diagnostic Tests (RDTs) for Malaria in Kampala, Uganda [clinicaltrials:NCT00327964]Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis [clinicaltrials:NCT00330148]Intermittent Versus Continuous HAART (Highly Active Antiretroviral Therapy) for Treating Chronic HIV Infected Patients in Uganda [clinicaltrials:NCT00339456]Validation of System for Monitoring the Effectiveness of Antiretroviral Therapy in HIV-Infected Patients in Africa [clinicaltrials:NCT00341393]Viral and Immunologic Factors Contributing to the Lack of HIV Transmission Among Couples in Rakai, Uganda [clinicaltrials:NCT00342160]Effect of Mass Deworming on Child Growth [clinicaltrials:NCT00344669]Examining Factors That May Influence Resistance to HIV-1 Infection [clinicaltrials:NCT00351442]Relationship Between HIV and Malaria in Ugandan Children [clinicaltrials:NCT00356824]Ceftriaxone Versus Chloramphenicol for Treatment of Severe Pneumonia in Children [clinicaltrials:NCT00372541]The Efficacy of Zinc as Adjunct Therapy in the Treatment of Severe Pneumonia in Children [clinicaltrials:NCT00373100]Sulfadoxine- Pyrimethamine Versus Weekly Chloroquine for Malaria Prevention in Children With Sickle Cell Anemia [clinicaltrials:NCT00399074]clinicaltrials:NCT00405821Male Circumcision for HIV Prevention in Rakai, Uganda [clinicaltrials:NCT00425984]Relationship of Viral Resistance Development to CD4 Monitoring Alone or With Viral Load Monitoring [clinicaltrials:NCT00434070]clinicaltrials:NCT00444379Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator Products [clinicaltrials:NCT00455585]Schistosomiasis in Formal and Non-Formal Schools in Uganda: Implications for Control Programmes [clinicaltrials:NCT00463593]Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda [clinicaltrials:NCT00489658]Quinine vs. Artemether/Lumefantrine in Uncomplicated Malaria During Pregnancy [clinicaltrials:NCT00495508]Transmission and the Respiratory Tract in Cryptosporidiosis [clinicaltrials:NCT00507871]clinicaltrials:NCT00527800clinicaltrials:NCT00540202Treatment of Posttraumatic Stress Disorder by Trained Lay Counsellors in an African Refugee Settlement [clinicaltrials:NCT00550056]
country [clinicaltrials_vocabulary:country]
Uganda [clinicaltrials_resource:53b3c88ea00c4f0e137b4e6fe7bd23f1]
Bio2RDF identifier
53b3c88ea00c4f0e137b4e6fe7bd23f1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:53b3c88ea00c4f0e137b4e6fe7bd23f1
identifier
clinicaltrials_resource:53b3c88ea00c4f0e137b4e6fe7bd23f1
title
Uganda
@en
type
label
Uganda [clinicaltrials_resource:53b3c88ea00c4f0e137b4e6fe7bd23f1]
@en